From: The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design
Group
The cases of diabetes
The incidence of diabetes mellitus (%)
The cases of normal blood glucose
Reversion rate (%)
The treatment group
30
16.5Â %
76
41.8Â %
The control group
52
28.9Â %
50
27.8Â %